Multiple Sclerosis (MS): Early Signs and Common Symptoms

People with multiple sclerosis tend to have their first symptoms between the ages of 20 and 40. Early on, the symptoms get better, but then they come back. This is called relapsing-remitting MS, and it's the most common type people have when they're diagnosed.Some people start with an episode of MS symptoms that doctors call clinically isolated syndrome . CIS could lead to MS, but it doesn’t always.

A vision problem called optic neuritis is one of the first signs of MS and CIS. It happens when inflammation damages the nerve that connects your eye to yourYou may have to pee more often, need to go during the night, or have trouble fully emptying your bladder. Bowel issues like constipation or trouble controlling when you poop are also common.You may feel lightheaded. Sometimes it can feel like the room is spinning. That’s called vertigo.

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

What causes multiple sclerosis—and why are women more at risk?Millions worldwide suffer from this debilitating disease. Symptoms vary widely, and there’s no known cure.
Source: NatGeo - 🏆 537. / 51 Read more »

Multiple Sclerosis Med Nearly Eliminates Disease Activity on MRIA second-generation anti-CD40L monoclonal antibody suppresses multiple sclerosis (MS) disease activity on MRI to an uncommonly high degree, new trial data suggested.
Source: Medscape - 🏆 386. / 55 Read more »

Dealing with decline from multiple sclerosisAs a multiple sclerosis patient ages, their condition may stop responding to regular treatment.
Source: KXDF News 13 - 🏆 266. / 63 Read more »

Mechanisms for selective multiple sclerosis treatment strategyResearchers have demonstrated how B cells infected with the Epstein-Barr virus (EBV) can contribute to a pathogenic, inflammatory phenotype that contributes to multiple sclerosis (MS); the group has also shown how these problematic B cells can be selectively targeted in a way that reduces the damaging autoimmune response of multiple sclerosis.
Source: ScienceDaily - 🏆 452. / 53 Read more »